Certolizumab-induced guttate psoriasiform dermatitis.

Fischer, Ryan; DaCunha, Matthew; Rajpara, Anand

Fischer, Ryan; DaCunha, Matthew; Rajpara, Anand.

Afiliação

Fischer R; Division of Dermatology, University of Kansas Medical Center, Kansas City. ryanfischeruk@gmail.com.

Dermatol Online J ; 23(1)2017 Jan 15.

Article em En | MEDLINE | ID: mdl-28329474

RESUMO

Certolizumab is a TNF inhibitor that has showngreat efficacy in chronic inflammatory diseases. Wereport a patient exhibiting a novel adverse effect ofcertolizumab: drug-induced guttate psoriasiformeruption. A review of the mechanism of psoriasiformdrug eruptions is also included.

Assuntos

Certolizumab Pegol/efeitos adversos; Doença de Crohn/tratamento farmacológico; Toxidermias/etiologia; Imunossupressores/efeitos adversos; Psoríase/induzido quimicamente; Adulto; Toxidermias/patologia; Humanos; Masculino; Psoríase/patologia

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Psoríase / Doença de Crohn / Toxidermias / Certolizumab Pegol / Imunossupressores Limite: Adult / Humans / Male Idioma: En Revista: Dermatol Online J Assunto da revista: DERMATOLOGIA Ano de publicação: 2017 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links